A 42-year-old female presented with an 8-week history of progressive generalized rash
and mucocutaneous ulcers associated with 50-pound weight loss. She had no personal
or family history of autoimmune disease. No recent illness or change in medications
before the onset of her rash.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy.Int J Mol Sci. 2017; 18: 2532https://doi.org/10.3390/ijms18122532
- Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa.Front Immunol. 2019; 10: 1259https://doi.org/10.3389/fimmu.2019.01259
- Laboratory diagnosis of paraneoplastic pemphigus.Br J Dermatol. 2013; 169: 1016-1024https://doi.org/10.1111/bjd.12479
- Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).Dermatol Clin. 2011; 29: 607-612https://doi.org/10.1016/j.det.2011.06.016
- Paraneoplastic pemphigus associated with b-cell chronic lymphocytic leukemia treated with ibrutinib and rituximab.Intern Med. 2018; 57: 2395-2398https://doi.org/10.2169/internalmedicine.0578-17
Article info
Publication history
Published online: February 20, 2021
Thomas J. Marrie, MD, Section EditorFootnotes
Funding: None.
Conflicts of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
